Top compounds associated with response to MED12L


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA bendamustine CTRPv2 pan-cancer AAC 0.12 0.002
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA AZD6244 CCLE pan-cancer AAC -0.15 0.002
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA nelarabine CTRPv2 pan-cancer AAC 0.12 0.002
mRNA XL765 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Merck60 CTRPv2 pan-cancer AAC 0.093 0.002
mRNA Erlotinib CCLE pan-cancer AAC -0.15 0.002
Download CSV